Related Experiment Video
Updated: Nov 30, 2025

15:29
Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
Published on: August 5, 2016
8.5K
Brucella canis Group 2 isolated in Argentina
Eduardo Jorge Boeri1, María Julia Madariaga1, María Luz Dominguez1
1Instituto de Zoonosis Luis Pasteur, Av. Diaz Velez 4821 (1405), Ciudad Autónoma de Buenos Aires, Argentina.
Revista Argentina De Microbiologia
|November 12, 2020
Summary
This study investigated Brucella canis diversity in Argentina, finding only Group 2 strains. Genetic analysis using MLVA-16 markers revealed diversity within this group, highlighting the importance of molecular typing for tracking bacterial evolution.
Area of Science:
- Veterinary Microbiology
- Bacteriology
- Genetics
Background:
- Brucella canis is a significant pathogen in canids.
- Understanding the genetic diversity and prevalence of B. canis groups is crucial for disease control.
- Previous studies have not fully characterized B. canis strains in Argentina.
Purpose of the Study:
- To estimate the diversity and prevalence of Brucella canis groups 1 and 2 in Argentina.
- To differentiate B. canis isolates from Brucella suis.
- To assess the genetic diversity of B. canis strains using molecular markers.
Main Methods:
- Classical biotyping of 104 bacterial cultures.
- Polymerase Chain Reaction (PCR) assays for B. canis confirmation and group differentiation.
- Multilocus Variable-number tandem repeat Analysis (MLVA-16) for genetic diversity assessment.
Main Results:
- All 104 isolates were confirmed as B. canis.
- Only Group 2 (with deletion) of B. canis was identified.
- The Bruce 09 marker within the MLVA-16 assay exhibited the highest genetic diversity among the strains.
Conclusions:
- The study identified a homogeneous population of Group 2 B. canis in the evaluated areas of Argentina.
- MLVA-16 markers are effective tools for detecting genetic diversity within B. canis populations.
- Further research is needed to understand the implications of Group 2 prevalence.

